KVISTGAARD, Denmark, September 23, 2014 - Bavarian Nordic A/S (OMX: BAVA) announced today its financial calendar for the year 2015. March 11, 2015 2014 Annual Report April 23, 2015 Annual General Meeting May 5, 2015 First quarterly report (Q1) for the three-month period ended 31 March 2015 August 25, 2015 Half-year report (Q2) for the six-month period ended 30 June 2015 November 3, 2015 Third quarterly report (Q3) for the nine-month period ended 30 September 2015 Pursuant to Article 12 of the Articles of Association, shareholders who wish to submit a request for proposals for consideration at the Annual General Meeting must lodge this with the Company no later than Friday, March 13, 2015. Moreover, it should be noted that Bavarian Nordic in a period of two weeks before planned publication of quarterly reports (silent periods), will not comment specifically on developments or financial issues and expectations. Contacts Rolf Sass Sørensen, Vice President Investor Relations (EU). Phone +45 61 77 47 43 Seth Lewis, Vice President Investor Relations (US). Phone + 1 978-298-5654 About Bavarian Nordic Bavarian Nordic is an international biotechnology company developing and manufacturing novel cancer immunotherapies and vaccines for infectious diseases. Lead product candidates are PROSTVAC(®), an immunotherapy product candidate for advanced prostate cancer that is the subject of an ongoing pivotal Phase 3 clinical trial, and IMVAMUNE(®), a non-replicating smallpox vaccine candidate in Phase 3 development, which is being developed and supplied for emergency use to the U.S. Strategic National Stockpile under a contract with the U.S. Government. IMVAMUNE is approved in Canada and in the European Union where it is marketed under the trade name IMVANEX(®). Bavarian Nordic's shares are listed on NASDAQ OMX Copenhagen under the symbol BAVA (Reuters: BAVA.CO, Bloomberg: BAVA.DC). The company has a sponsored Level 1 ADR program listed in the U.S. (OTC) under the symbol BVNRY. For more information, visit www.bavarian-nordic.com. Forward-looking statements This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law. [HUG#1857344]
Bavarian Nordic issues Financial Calendar for 2015
Top 10 Most Recent News Articles
Succession Planning in Turmoil: Only 42% Ready
Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...
Continue Reading
The Chemical Industry and EPA: A Broken System?
Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...
Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom
Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...
Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio
Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...
Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead
Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...
Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier
Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...
Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus
Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...
Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows
Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...
Continue Reading
Leapora's Taskeen: Redefining Task Accountability
AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...
Continue ReadingTop 5 Most Recently Viewed Articles
Ascendis Pharma Reports Q2 2024 Results and Positive Outlook
Ascendis Pharma Reports Mixed Q2 Results Ascendis Pharma A/S (NASDAQ: ASND) has unveiled its financial results for the second quarter of 2024, revealing a mix of achievements and hurdles. A significant highlight of this quarter was the U.S. approval of YORVIPATH for the treatment of adult hypoparathyroidism. This marks a major milestone as it represents the company's...
Continue Reading
Analyzing New Zealand's Economic Growth and Monetary Policy Shifts
New Zealand’s Economic Growth Overview New Zealand's latest growth figures present a significant turning point for a nation that has been adjusting to the impacts of substantial monetary easing. The economy showed a quarterly expansion of 1.1%, bouncing back after a contraction of 1.0% previously. This growth not only exceeded expectations, which were around 0.9%, but...
Continue Reading
Eli Lilly's Competitive Landscape in the Pharmaceuticals Sector
Exploring Eli Lilly's Impact on the Pharmaceuticals Sector In the dynamic and competitive world of pharmaceuticals, understanding the role of companies like Eli Lilly & Co. (NYSE: LLY) is crucial for investors and stakeholders alike. This article offers a detailed comparative analysis of Eli Lilly's performance against its main competitors, focusing on key financial...
Continue Reading
Veriff Welcomes Tech Visionary Ott Kaukver to Its Board
Veriff Expands Its Board with Industry Expertise Veriff, an innovative identity verification company known for its AI-native technology, recently appointed Ott Kaukver to its Board of Directors. This significant move illustrates the company’s determination to enhance trust in online identities globally. Kaukver, recognized for his role as the former CTO of Twilio and...
Continue Reading
University of Phoenix's New Initiative Promotes Responsible AI Use
University of Phoenix Launches Center for AI Resources University of Phoenix has taken a significant step towards empowering its students and faculty by launching the Center for AI Resources. This initiative is designed to equip learners with essential knowledge for navigating the increasingly complex landscape of generative AI (GenAI). The Center serves as a...
Continue Reading